For the Inventor, By the Inventor

Enter assignee name

Huddinge, Sweden

Tripep Ab

USPTO Granted Patents = 35

% Expired Patents = 80.0

EPO Patents = 1

Forward Citations = 237

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Matti Sällberg (24 out of 39 patents)

Anders Vahlne (10 out of 12 patents)

Catharina Hultgren (6 out of 6 patents)

4. Matti Sällberg (5 out of 5 patents)

5. Maria Perdomo (4 out of 6 patents)

6. Laura Goobar-Larsson (4 out of 4 patents)

7. Sarah Sandin-Reneby (3 out of 3 patents)

8. Jin Su (3 out of 3 patents)

9. Stefan Höglund (3 out of 3 patents)

10. Ákos Végvári (3 out of 3 patents)

11. Csaba Hetényi (3 out of 3 patents)

12. David Van Der Spoel (3 out of 3 patents)

13. Lars Frelin (2 out of 8 patents)

14. Robert Kamen (1 out of 3 patents)

15. Jan-Ingmar Flock (1 out of 9 patents)

35 patents: Sort by Forward Citations

1. 9457183 - Injection needle and device (2016-10-04),

2. 9284548 - High affinity adaptor molecules for redirecting antibody specifity (2016-03-15),

3. 9193778 - T cell receptors specific for immunodominant CTL epitopes of HCV (2015-11-24),

4. 9079962 - Glycosylated specificity exchangers (2015-07-14),

5. 7638499 - Hepatitis C virus codon optimized non-structural NS3/4A fusion gene (2009-12-29),

6. 7566812 - Transgenic mouse models of hepatitis C virus (HCV) and identification of HCV therapeutics (2009-07-28),

7. 7534435 - Glycosylated specificity exchangers (2009-05-19),

8. 7439347 - Hepatitis C virus non-structural NS3/4A fusion gene (2008-10-21),

9. 7335359 - Glycosylated specificity exchangers (2008-02-26),

10. 7332166 - Glycosylated specificity exchangers (2008-02-19),

11. 7318926 - Glycosylated specificity exchangers (2008-01-15),

12. 7307066 - Hepatitis C virus codon optimized non-structural NS3/4A fusion gene (2007-12-11),

13. 7261883 - Vaccines containing ribavirin and methods of use thereof (2007-08-28),

14. 7244715 - Vaccines containing ribavirin and methods of use thereof (2007-07-17),

15. 7244422 - Vaccines containing ribavirin and methods of use thereof (2007-07-17),

TRIPEP AB is a Swedish biotechnology company specializing in peptide synthesis and related services. Founded in 1999, the company has grown to become a leading provider of high-quality custom peptides for research, pharmaceutical, and diagnostic purposes. With a state-of-the-art facility and experienced team, TRIPEP offers a wide range of peptide synthesis technologies and modifications, along with peptide purification and analytical services. Dedicated to delivering innovative solutions, TRIPEP collaborates with academic and industrial partners to contribute to advancements in healthcare and life sciences.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

35 Patents

#2 in Huddinge

#196 in Sweden

#19,119 in the World

Huddinge, Sweden

Tripep Ab

Forward Citations = 237

19 inventors:

Matti Sällberg (24 out of 39 patents)

Anders Vahlne (10 out of 12 patents)

Catharina Hultgren (6 out of 6 patents)

4. Matti Sällberg (5 out of 5 patents)

5. Maria Perdomo (4 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…